Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01818427 · ClinicalTrials.gov registry record · Phase 3
PreHospital Air Medical Plasma Trial
A Phase 3 study, sponsored by Jason Sperry.
- Completed
- Registry status
- Phase 3
- Development phase
- 523
- Enrollment target
NCT01818427 is a Phase 3 study that has completed, run by Jason Sperry. The registered enrollment target is 523 participants.
The verdict
NCT01818427, a Phase 3 study, has completed, sponsored by Jason Sperry.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 523 participants
- Enrollment target
Study Summary
To determine the effect of the prehospital infusion during air transport of 2 units of AB plasma on 30 day mortality in patients with hemorrhagic shock as compared to conventional care.
Interventions
- BIOLOGICAL infusion of 2 units of plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 523 participants |
| Start Date | 2014-05 |
| Est. Completion | 2017-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01818427
The ClinicalTrials.gov registry entry for NCT01818427 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 523 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jason Sperry, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which infusion of 2 units of plasma is the first listed.
NCT01818427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01818427 about?
NCT01818427 is a clinical study titled "PreHospital Air Medical Plasma Trial". To determine the effect of the prehospital infusion during air transport of 2 units of AB plasma on 30 day mortality in patients with hemorrhagic shock as compared to conventional care.
What is the current status of trial NCT01818427?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 523 participants. The study started on 2014-05. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01818427?
The interventions under investigation include: infusion of 2 units of plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT01818427?
This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.